HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Hanby Selected Research

Breast Neoplasms (Breast Cancer)

4/2014Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer.
2/2014Germline CDH1 mutations in bilateral lobular carcinoma in situ.
7/2006Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast.
5/2006Properties and characteristics of the dyes injected to assist axillary sentinel node localization in breast surgery.
5/2006Hormone dependency of breast tumours developing in the Guernsey Cohort study.
4/2003Fibroblast growth factor 7, secreted by breast fibroblasts, is an interleukin-1beta-induced paracrine growth factor for human breast cells.
10/2000Immunohistochemical expression of uPA, uPAR, and PAI-1 in breast carcinoma. Fibroblastic expression has strong associations with tumor pathology.
10/2000A study of the value of p53, HER2, and Bcl-2 in the prediction of response to doxorubicin and paclitaxel as single agents in metastatic breast cancer: a companion study to EORTC 10923.
5/2000Effective tamoxifen therapy of breast cancer involves both antiproliferative and pro-apoptotic changes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Hanby Research Topics

Disease

9Breast Neoplasms (Breast Cancer)
04/2014 - 05/2000
7Neoplasms (Cancer)
05/2006 - 02/2000
3Noninfiltrating Intraductal Carcinoma (DCIS)
01/2015 - 01/2007
2Carcinoma (Carcinomatosis)
01/2007 - 08/2000
1Breast Carcinoma In Situ
02/2014
1Carcinoma in Situ
01/2007
1Breast Diseases (Breast Disease)
01/2007
1Hypersensitivity (Allergy)
05/2006
1Lobular Carcinoma
05/2001
1Salivary Gland Neoplasms (Salivary Gland Cancer)
11/2000
1Peutz-Jeghers Syndrome (Polyposis, Hamartomatous Intestinal)
10/2000
1Duodenogastric Reflux
08/2000
1Adenosquamous Carcinoma
08/2000
1Carcinogenesis
02/2000
1Adenoma (Adenomas)
02/2000
1Colorectal Neoplasms (Colorectal Cancer)
02/2000
1Microsatellite Instability
02/2000
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
02/2000

Drug/Important Bio-Agent (IBA)

3Cadherins (E-Cadherin)IBA
02/2014 - 11/2000
3Proteins (Proteins, Gene)FDA Link
01/2007 - 02/2000
2taxaneIBA
04/2014 - 10/2000
1Docetaxel (Taxotere)FDA Link
04/2014
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
04/2014
1Taxoids (Taxanes)IBA
04/2014
1ParaffinIBA
01/2007
1Caspase 1 (ICE Protease)IBA
01/2007
1Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2007
1Formaldehyde (Formol)FDA Link
01/2007
1Keratins (Keratin)IBA
07/2006
1Estrogen ReceptorsIBA
05/2006
1iso-sulfan blue (Lymphazurin)FDA LinkGeneric
05/2006
1Coloring Agents (Dyes)IBA
05/2006
1Estradiol (Delestrogen)FDA LinkGeneric
05/2006
1Estrogens (Estrogen)FDA Link
05/2006
1Methylene Blue (Methylthioninium Chloride)FDA Link
05/2006
1Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
04/2003
1Proteoglycans (Proteoglycan)IBA
04/2003
1Plasminogen Activator Inhibitor 1IBA
10/2000
1Monoclonal AntibodiesIBA
10/2000
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2000
1Plasminogen Activators (Plasminogen Activator)IBA
10/2000
1Tumor Biomarkers (Tumor Markers)IBA
10/2000
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
10/2000
1Paclitaxel (Taxol)FDA LinkGeneric
10/2000
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
10/2000
1AnthracyclinesIBA
10/2000
1Urokinase Plasminogen Activator ReceptorsIBA
10/2000
1ElementsIBA
08/2000
1CarcinogensIBA
08/2000
1TamoxifenFDA LinkGeneric
05/2000
1beta CateninIBA
02/2000
1alpha Catenin (alpha E-Catenin)IBA
02/2000

Therapy/Procedure

3Therapeutics
04/2014 - 05/2000
2Mastectomy (Mammectomy)
01/2015 - 01/2010
1Adjuvant Chemotherapy
04/2014